Impel Drug Patent Portfolio
Impel owns 1 orange book drug protected by 6 US patents Given below is the list of Impel's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11185497 | Intranasal delivery of dihydroergotamine by precision olfactory device | 04 Jan, 2039 | Active |
| US11266799 | In-line nasal delivery device | 05 Nov, 2036 | Active |
| US9919117 | Nozzles for nasal drug delivery | 17 Mar, 2033 | Active |
| US10940278 | Nozzles for nasal drug delivery | 23 Jan, 2033 | Active |
| US10507295 | Nasal drug delivery device | 25 Dec, 2032 | Active |
| US9550036 | Nasal drug delivery device | 05 Sep, 2032 | Active |
Latest Legal Activities on Impel's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Impel.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 8th Yr, Small Entity | 03 Sep, 2025 | US9919117 |
| Payment of Maintenance Fee, 4th Yr, Small Entity | 27 Aug, 2025 | US11266799 |
| Payment of Maintenance Fee, 4th Yr, Small Entity | 14 May, 2025 | US11185497 |
| Email Notification | 24 Sep, 2024 | US10940278 |
| Change in Power of Attorney (May Include Associate POA) | 24 Sep, 2024 | US10940278 |
| Change in Power of Attorney (May Include Associate POA) | 23 Sep, 2024 | US11266799 |
| Email Notification | 23 Sep, 2024 | US11266799 |
| Email Notification | 23 Sep, 2024 | US10507295 |
| Email Notification | 23 Sep, 2024 | US9919117 |
| Change in Power of Attorney (May Include Associate POA) | 23 Sep, 2024 | US10507295 |
| Change in Power of Attorney (May Include Associate POA) | 23 Sep, 2024 | US9550036 |
| Email Notification | 23 Sep, 2024 | US9550036 |
| Change in Power of Attorney (May Include Associate POA) | 23 Sep, 2024 | US9919117 |
| Email Notification | 20 Sep, 2024 | US11185497 |
| Change in Power of Attorney (May Include Associate POA) | 20 Sep, 2024 | US11185497 |
Impel's Family Patents
Impel Drug List
Given below is the complete list of Impel's drugs and the patents protecting them.
1. Trudhesa
Trudhesa is protected by 6 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11185497 | Intranasal delivery of dihydroergotamine by precision olfactory device |
04 Jan, 2039
(12 years from now)
| Active |
| US11266799 | In-line nasal delivery device |
05 Nov, 2036
(10 years from now)
| Active |
| US9919117 | Nozzles for nasal drug delivery |
17 Mar, 2033
(7 years from now)
| Active |
| US10940278 | Nozzles for nasal drug delivery |
23 Jan, 2033
(6 years from now)
| Active |
| US10507295 | Nasal drug delivery device |
25 Dec, 2032
(6 years from now)
| Active |
| US9550036 | Nasal drug delivery device |
05 Sep, 2032
(6 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Trudhesa's drug page